AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...

AstraZeneca succeeded in thwarting Pfizer's takeover plans – but was forced to promise investors that it could deliver very rapid growth – forecasting revenues of $45 billion by 2023, compared ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

The year 2021 was one of big impact for pharmaceutical leader AstraZeneca ... pharmaceutical and biotechnology leader based in Cambridge, England, has also made sure to focus squarely on the ...